Approved for ZYCUBO is indicated for the treatment of Menkes disease in pediatric patients. Limitations of Use: ZYCUBO is not indicated for the treatment of Occipital Horn Syndrome.. ZYCUBO is a bioavailable copper replacement therapy for Menkes disease caused by pathogenic variants in ATP7A. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…
Loading full data from Know Your Drugs Institute…